Therapeutics News and Research

RSS

Researchers discover network of neural regions involved in spread of seizures

A flurry of coordinated activity in a brain-spanning network of neurons may sound like the formation of a brilliant new idea, but it is actually the description of a seizure. Understanding why and how this synchronization spreads would be a critical tool in treating severe epilepsy.

13 Sep 2016

ATR inhibitors show improved survival and effectiveness in animal models of cancer

Tumours are an accumulation of cells that divide without control, accumulating hundreds of chromosomal alterations and mutations in their DNA.

13 Sep 2016

Novel DNA-altering method could lead to more treatment options for diseases

Researchers in Singapore have developed a new protein that can alter DNA in living cells with much higher precision than current methods.

13 Sep 2016

Isolation of human NP cells may offer way to foster renal regeneration after chronic kidney failure

In a first-of-its-kind look at human kidney development, researchers at The Saban Research Institute of Children's Hospital Los Angeles have isolated human nephron progenitor (NP) cells.

12 Sep 2016

Using the immune system to fight cancer: an interview with Dr Charles Akle

We all produce as many as 100,000 different types of cancer cells every day, which are recognized and eliminated by our extraordinarily efficient immune system. However, if something goes wrong with the immune system, and it no longer gets rid of these cells, then that’s when cancerous cells grow and become a problem.

12 Sep 2016

Scientists use insect model to reveal therapeutic potential of C. difficile bacteriophages

University of Leicester scientists have previously identified the potential of using a bacteriophage cocktail to eradicate Clostridium difficile infection (CDI) and in this research, using an insect model, they show that their prophylactic use can prevent infection forming in the first place.

12 Sep 2016

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.

9 Sep 2016

Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

In a paper published today in Science Translational Medicine, researchers from Fred Hutchinson Cancer Research Center shared data from an early-phase study of patients with advanced non-Hodgkin lymphoma (NHL) who received JCAR014, a Chimeric Antigen Receptor (CAR) T cell treatment, and chemotherapy.

9 Sep 2016

MIT biologists unravel lncRNA structure-to-function relationships

Several years ago, biologists discovered a new type of genetic material known as long noncoding RNA. This RNA does not code for proteins and is copied from sections of the genome once believed to be "junk DNA."

9 Sep 2016

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

In research published online today in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus.

8 Sep 2016

Researchers reveal potential therapeutic treatment for alphavirus infections

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment for the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus (RRV) and Chikungunya Virus (CHIKV).

8 Sep 2016

Researchers unlock genetic code that disrupts response to breast cancer therapy

Scientists may have unlocked the genetic code that determines why many patients with estrogen receptor-positive breast cancer fail to respond to the widely used drug tamoxifen.

7 Sep 2016

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Scientists at Cedars-Sinai have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk.

7 Sep 2016

Caltech scientists uncover three-dimensional structure of disease-fighting protein

The polymeric immunoglobulin receptor, or pIgR, is a multitasking protein produced in the lining of mucosal surfaces, such as the intestines. It plays a pivotal role in the body's immune functions by sequestering bacteria and by assisting antibodies—large proteins that can identify and neutralize specific bacteria and viruses.

6 Sep 2016

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD), an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten.

6 Sep 2016

Researchers use unique computational approach to identify promising drug leads for heart diseases

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure.

6 Sep 2016

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

Therapeutics News and Research

Researchers discover network of neural regions involved in spread of seizures

ATR inhibitors show improved survival and effectiveness in animal models of cancer

Novel DNA-altering method could lead to more treatment options for diseases

Isolation of human NP cells may offer way to foster renal regeneration after chronic kidney failure

Using the immune system to fight cancer: an interview with Dr Charles Akle

Scientists use insect model to reveal therapeutic potential of C. difficile bacteriophages

New study raises safety concerns on clinical use of caspase inhibitors for liver diseases

Right dose of CAR T cells and lymphodepletion can achieve good response rates for NHL patients

MIT biologists unravel lncRNA structure-to-function relationships

Novel Trojan Horse antibody strategy may target Ebola's Achilles' heel

Researchers reveal potential therapeutic treatment for alphavirus infections

Researchers unlock genetic code that disrupts response to breast cancer therapy

Cedars-Sinai researchers develop new way to identify patients at risk for aggressive prostate cancer

Caltech scientists uncover three-dimensional structure of disease-fighting protein

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers use unique computational approach to identify promising drug leads for heart diseases

HIF-2 inhibitors could be promising target to combat kidney cancer

Researchers describe how genetic mutations cause unnamed neurological disorder

ToMMo scientists identify genetic variants affecting enzymatic activities in healthy people

Monoclonal antibody removes brain amyloid plaques in patients with Alzheimer's disease

Next-generation therapeutics eBook eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News